Press-release for stocks for SRNE

Prices are updated after-hours

| -99.76% | O: -0.48% H: 0.72% C: -1.33%
covid genomic diagnostics diagnostic

Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
Published: 2021-08-03 (Crawled : 13:15) - prnewswire.com
SRNE | $0.024 -8.85% 57K

| -99.76% | O: -0.48% H: 0.72% C: -1.33%
REPL | $6.47 -7.17% -7.73% 870K

| -80.66% | O: 0.84% H: 3.45% C: 1.78%
ONCR | $0.126 -75.95% 140K

| -98.97% | O: -0.24% H: 1.98% C: -1.74%
immunotherapy therapy cancer

67%

33%

Save your searches and get alerts when important news are released.